GlassScriptPhysician profile
Paresh P Shukla
NPI 1477618767
$31,463.61
in general payments reported to CMS, 2019-2025
62 companies · $2,796 in 2025
The $2,796 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,521 · 2020: $3,616 · 2021: $5,093 · 2022: $4,115 · 2023: $6,326 · 2024: $4,997 · 2025: $2,796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $81.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,036.91 |
| Education | $81.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $4,701.35 | 2019-2025 | Evenity, Repatha, Otezla |
| Glaxosmithkline, LLC. | $3,126.66 | 2019-2025 | Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $2,870.65 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,478.57 | 2019-2024 | Jardiance, Synjardy |
| Abbvie INC. | $2,188.22 | 2019-2025 | Vraylar, Linzess, Viberzi |
| Janssen Pharmaceuticals, INC | $1,828.72 | 2019-2024 | Xarelto, Spravato |
| Novo Nordisk INC | $1,553.49 | 2019-2025 | Rybelsus, Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,016.22 | 2019-2024 | Trulance, Xifaxan |
| Kowa Pharmaceuticals America, INC. | $1,013.79 | 2019-2025 | Livalo, Seglentis, Zoryve |
| Pfizer INC. | $657.88 | 2019-2024 | |
| Lilly USA, LLC | $652.72 | 2019-2024 | Jardiance, Mounjaro, Emgality |
| Allergan, INC. | $621.93 | 2019-2021 | |
| Amarin Pharma, INC. | $587.61 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $580.55 | 2021-2025 | |
| Ardelyx, INC. | $531.18 | 2023-2025 | Ibsrela |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $450.24 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $429.30 | 2023-2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $402.00 | 2024-2025 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $388.90 | 2019-2024 | Eliquis |
| Novartis Pharmaceuticals Corporation | $388.12 | 2019-2024 | |
| Otsuka America Pharmaceutical, INC. | $386.63 | 2019-2025 | Rexulti |
| Intuity Medical INC | $367.10 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Sumitomo Pharma America, INC. | $309.79 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $303.17 | 2019-2023 | Veozah |
| Sanofi-Aventis U.S. LLC | $281.25 | 2019-2022 | |
| Medtronic, INC. | $274.22 | 2023-2025 | Interstim, Corevalve Evolut R |
| Sunovion Pharmaceuticals INC. | $261.79 | 2019-2021 | |
| Abiomed | $259.53 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $220.20 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Mannkind Corporation | $219.58 | 2019-2021 | |
| Radius Health, INC. | $190.67 | 2019-2021 | |
| Corcept Therapeutics | $157.52 | 2025 | Korlym |
| Medtronic Vascular, INC. | $141.29 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $127.10 | 2019-2023 | Trintellix |
| Philips North America LLC | $109.97 | 2021-2024 | (Ak6) Vest Therapy |
| Azurity Pharmaceuticals, INC. | $104.73 | 2023-2024 | Edarbi, Horizant, Edarbyclor |
| Eisai INC. | $103.33 | 2020-2021 | |
| Cardiovascular Systems INC. | $102.94 | 2021 | |
| Biogen, INC. | $101.14 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.16 | 2023 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $98.62 | 2023 | Inpefa |
| Paratek Pharmaceuticals, INC. | $71.82 | 2021 | |
| Janssen Biotech, INC. | $70.48 | 2019 | |
| Horizon Therapeutics Plc | $70.20 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $68.48 | 2019-2022 | |
| Mylan Specialty L.P. | $65.92 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $52.35 | 2020-2024 | |
| Lundbeck LLC | $51.67 | 2023-2025 | Rexulti |
| Almatica Pharma LLC | $41.43 | 2021-2023 | Gralise, Loreev Xr, Sertraline Hcl |
| Dexcom, INC. | $39.48 | 2021-2024 | Dexcom G6 Transmitter |
| Althera Pharmaceuticals LLC | $34.66 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $29.86 | 2019 | |
| Avanir Pharmaceuticals, INC. | $28.29 | 2020-2021 | |
| Edwards Lifesciences Corporation | $21.25 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Verona Pharma, INC. | $19.50 | 2025 | Ohtuvayre |
| Teva Pharmaceuticals USA, INC. | $18.99 | 2019 | |
| Boston Scientific Corporation | $18.69 | 2019 | |
| Esperion Therapeutics, INC. | $16.83 | 2023 | Nexletol |
| Idorsia Pharmaceuticals US INC | $14.44 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $14.17 | 2022 | |
| Nevro Corp. | $13.77 | 2021 | |
| Shield Therapeutics INC | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paresh Shukla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.